Skip to main content
Addgene
Open Menu

Enter a sequence to perform a BLAST-based search of Addgene plasmid sequence databases.

Information

In Category

Filter By

We narrowed to 8,901 results for: aav

Clear keywords
Showing: 8681 - 8700 of 8901 results

  1. pHL 1903

    Plasmid
    #53020
    Purpose
    AmpR + fimS::gfpAAV::Asp terminator + CamR + ColE1
    Depositor
    Han Lim
    Article
    Hung et al Nat Commun. 2014 Aug 4;5:4574. doi: 10.1
    Insert
    GFP
    Use
    Synthetic Biology
    Tags
    AAV, Asp terminator, and fimS
    Expression
    Bacterial
    Promoter
    fimS
    Available Since
    May 14, 2014
    Availability
    Academic Institutions and Nonprofits only

  3. pAAV-hsyn-GRAB_Ado1.0 (AAV1)

    Viral Prep
    #153285-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from pAAV-hsyn-GRAB_Ado1.0 (#153285). In addition to the viral particles, you will also receive purified pAAV-hsyn-GRAB_Ado1.0 plasmid DNA. hSyn-driven expression of GRAB_Ado1.0 adenosine sensor in neurons. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Yulong Li
    Article
    Peng et al Science. 2020 Sep 4;369(6508). pii: 369/
    Promoter
    Syn
    Available Since
    Feb. 9, 2026
    Availability
    Academic Institutions and Nonprofits only

  4. pAAV-GFAP104-ChR2-mCherry (AAV5)

    Viral Prep
    #58892-AAV5
    Purpose
    Ready-to-use AAV5 particles produced from pAAV-GFAP104-ChR2-mCherry (#58892). In addition to the viral particles, you will also receive purified pAAV-GFAP104-ChR2-mCherry plasmid DNA. GFAP -driven, expression of humanized ChR2 H134R mutant fused to mCherry, for optogenetic activation. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Edward Boyden
    Article
    Perea et al Nat Commun. 2014;5:3262. doi: 10.1038/nc
    Promoter
    GFAP104
    Available Since
    Jan. 14, 2026
    Availability
    Academic Institutions and Nonprofits only

  5. pAAV-Ef1a-DIO_EGFP-GFE3 (AAV1)

    Viral Prep
    #79871-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from pAAV-Ef1a-DIO_EGFP-GFE3 (#79871). In addition to the viral particles, you will also receive purified pAAV-Ef1a-DIO_EGFP-GFE3 plasmid DNA. EF1a-driven, Cre-dependent expression of GFP-GFE3. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Don Arnold
    Article
    Gross et al Nat Methods. 2016 Jun 6. doi: 10.1038/nm
    Promoter
    EF1a
    Available Since
    Nov. 13, 2025
    Availability
    Academic Institutions and Nonprofits only

  6. AiP14871: pAAV-AiE0779m_3xC2-minBG-RiboL1-jGCaMP8s-WPRE3-BGHpA (Alias: CN4871) (AAV1)

    Viral Prep
    #214865-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from AiP14871: pAAV-AiE0779m_3xC2-minBG-RiboL1-jGCaMP8s-WPRE3-BGHpA (Alias: CN4871) (#214865). In addition to the viral particles, you will also receive purified AiP14871: pAAV-AiE0779m_3xC2-minBG-RiboL1-jGCaMP8s-WPRE3-BGHpA (Alias: CN4871) plasmid DNA. Neuronal expression of soma-targeted (RL-10, ribosomal tag) jGCaMP8s under the minBG promoter. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Allen Institute for Brain Science, Jonathan Ting
    Article
    Hunker et al Neuron. 2025 May 21;113(10):1507-1524.e1
    Available Since
    Nov. 13, 2025
    Availability
    Academic Institutions and Nonprofits only

  7. pAAV_BiPVe4_ChR2_mCherry (AAV1)

    Viral Prep
    #213937-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from pAAV_BiPVe4_ChR2_mCherry (#213937). In addition to the viral particles, you will also receive purified pAAV_BiPVe4_ChR2_mCherry plasmid DNA. Expression of mCherry-tagged channelrhodopsin-2 under the control of the chandelier cell-targeting enhancer E4. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Gordon Fishell
    Article
    Furlanis et al Neuron. 2025 May 21;113(10):1525-1547.e1
    Tags
    mCherry
    Available Since
    Sept. 23, 2025
    Availability
    Academic Institutions and Nonprofits only

  8. pAAV_BiVIPe4_dTomato_nlsdTomato (AAV1)

    Viral Prep
    #213855-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from pAAV_BiVIPe4_dTomato_nlsdTomato (#213855). In addition to the viral particles, you will also receive purified pAAV_BiVIPe4_dTomato_nlsdTomato plasmid DNA. Bicistronic expression of dTomato and nuclear-targeted dTomato under the control of the VIP interneuron-targeting enhancer E4. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Gordon Fishell
    Article
    Furlanis et al Neuron. 2025 May 21;113(10):1525-1547.e1
    Tags
    dTomato
    Available Since
    Sept. 23, 2025
    Availability
    Academic Institutions and Nonprofits only

  9. pAAV_BiSSTe4_GCaMP6f (AAV1)

    Viral Prep
    #213947-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from pAAV_BiSSTe4_GCaMP6f (#213947). In addition to the viral particles, you will also receive purified pAAV_BiSSTe4_GCaMP6f plasmid DNA. Expression of GCaMP6f under the control of the SST interneuron-targeting enhancer E4. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Gordon Fishell
    Article
    Furlanis et al Neuron. 2025 May 21;113(10):1525-1547.e1
    Available Since
    Sept. 23, 2025
    Availability
    Academic Institutions and Nonprofits only

  10. pAAV-hSyn-EGFP (AAV11 trial size)

    Viral Prep
    #50465-AAV11.T
    Purpose
    Ready-to-use AAV11 trial size particles produced from pAAV-hSyn-EGFP (#50465). In addition to the viral particles, you will also receive purified pAAV-hSyn-EGFP plasmid DNA. hSyn-driven EGFP expression. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Bryan Roth
    Promoter
    Syn
    Tags
    EGFP
    Available Since
    July 16, 2025
    Availability
    Academic Institutions and Nonprofits only

  11. pAAV-CAG-emiRFP670 (AAV1)

    Viral Prep
    #197200-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from pAAV-CAG-emiRFP670 (#197200). In addition to the viral particles, you will also receive purified pAAV-CAG-emiRFP670 plasmid DNA. CAG-driven expression of emiRFP670. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Kiryl Piatkevich
    Article
    Zhang et al Nat Methods. 2023 Sep 4. doi: 10.1038/s4
    Available Since
    Feb. 7, 2025
    Availability
    Academic Institutions and Nonprofits only

  12. pAAV-CAG-eYFP (AAV5)

    Viral Prep
    #104055-AAV5
    Purpose
    Ready-to-use AAV5 particles produced from pAAV-CAG-eYFP (#104055). In addition to the viral particles, you will also receive purified pAAV-CAG-eYFP plasmid DNA. CAG-driven eYFP expression control. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Viviana Gradinaru
    Article
    Challis et al Nat Protoc. 2019 Feb;14(2):379-414. doi:
    Promoter
    CAG
    Tags
    EYFP
    Available Since
    Sept. 27, 2023
    Availability
    Academic Institutions and Nonprofits only

  13. pAAV-mDlx-GFP-Fishell-1 (AAV8)

    Viral Prep
    #83900-AAV8
    Purpose
    Ready-to-use AAV8 particles produced from pAAV-mDlx-GFP-Fishell-1 (#83900). In addition to the viral particles, you will also receive purified pAAV-mDlx-GFP-Fishell-1 plasmid DNA. mDlx-driven expression of GFP in GABA-ergic interneurons. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Gordon Fishell
    Article
    Dimidschstein et al Nat Neurosci. 2016 Oct 31. doi: 10.1038/
    Promoter
    mDlx
    Available Since
    May 22, 2023
    Availability
    Academic Institutions and Nonprofits only

  14. pAAV-EF1a-iFlpV (AAV1)

    Viral Prep
    #140137-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from pAAV-EF1a-iFlpV (#140137). In addition to the viral particles, you will also receive purified pAAV-EF1a-iFlpV plasmid DNA. EF1a-driven, light-inducible iFlpV recombinase for spatiotemporally precise optogenomic modifications. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Hongkui Zeng
    Article
    Yao et al Nat Methods. 2020 Mar 23. pii: 10.1038/s
    Promoter
    EF1a
    Available Since
    Oct. 28, 2021
    Availability
    Academic Institutions and Nonprofits only

  15. pAAV-synapsin-HaloCaMP1a-EGFP (AAV1)

    Viral Prep
    #138327-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from pAAV-synapsin-HaloCaMP1a-EGFP (#138327). In addition to the viral particles, you will also receive purified pAAV-synapsin-HaloCaMP1a-EGFP plasmid DNA. Synapsin-driven HaloCaMP1a, a far-red calcium sensor, fused to EGFP. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Eric Schreiter
    Article
    Deo et al Nat Chem Biol. 2021 Jun;17(6):718-723. d
    Promoter
    Syn
    Tags
    EGFP
    Available Since
    Sept. 15, 2021
    Availability
    Academic Institutions and Nonprofits only

  17. pAAV-hSyn-Kir2.1Mut-2A-mScarlet-KASH (AAV2)

    Viral Prep
    #203841-AAV2
    Purpose
    Ready-to-use AAV2 particles produced from pAAV-hSyn-Kir2.1Mut-2A-mScarlet-KASH (#203841). In addition to the viral particles, you will also receive purified pAAV-hSyn-Kir2.1Mut-2A-mScarlet-KASH plasmid DNA. hSyn-driven expression of mutant murine Kir2.1 and mScarlet-KASH. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Ivo Spiegel
    Article
    Roethler et al Neuron. 2023 Jun 20:S0896-6273(23)00399-
    Available Since
    Feb. 9, 2026
    Availability
    Academic Institutions and Nonprofits only

  18. pAAV-hSyn-Kir2.1WT-2A-mScarlet-KASH (AAV2)

    Viral Prep
    #203840-AAV2
    Purpose
    Ready-to-use AAV2 particles produced from pAAV-hSyn-Kir2.1WT-2A-mScarlet-KASH (#203840). In addition to the viral particles, you will also receive purified pAAV-hSyn-Kir2.1WT-2A-mScarlet-KASH plasmid DNA. hSyn-driven expression of Kir2.1 and mScarlet-KASH. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Ivo Spiegel
    Article
    Roethler et al Neuron. 2023 Jun 20:S0896-6273(23)00399-
    Tags
    mScarlett
    Available Since
    Feb. 6, 2026
    Availability
    Academic Institutions and Nonprofits only

  19. pAAV-rtTA (AAV1)

    Viral Prep
    #175274-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from pAAV-rtTA (#175274). In addition to the viral particles, you will also receive purified pAAV-rtTA plasmid DNA. Syn-driven expression of reverse tetracycline-controlled transactivator. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Wei Xu
    Article
    Li et al Nat Methods. 2021 Nov 25. pii: 10.1038/s
    Promoter
    Syn
    Available Since
    Jan. 15, 2026
    Availability
    Academic Institutions and Nonprofits only

  20. AiP15571: pAAV-AiE1426m-minBG-iCre(R297T)-BGHpA (Alias: CN5571) (AAV2)

    Viral Prep
    #230877-AAV2
    Purpose
    Ready-to-use AAV2 particles produced from AiP15571: pAAV-AiE1426m-minBG-iCre(R297T)-BGHpA (Alias: CN5571) (#230877). In addition to the viral particles, you will also receive purified AiP15571: pAAV-AiE1426m-minBG-iCre(R297T)-BGHpA (Alias: CN5571) plasmid DNA. minBG-driven expression of iCre(R297T) in striatal Sst-Chodl interneurons. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Allen Institute for Brain Science, Jonathan Ting
    Article
    Hunker et al Neuron. 2025 May 21;113(10):1507-1524.e1
    Available Since
    Nov. 14, 2025
    Availability
    Academic Institutions and Nonprofits only
Showing: 8681 - 8700 of 8901 results